» Articles » PMID: 35353882

The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance

Abstract

Background: Approximately 3% of the population suffers a first episode of psychosis (FEP), and a high percentage of these patients subsequently relapse. Because the clinical course following a FEP is hard to predict, it is of interest to identify cognitive and biological markers that will help improve the diagnosis, treatment, and outcome of such events and to define new therapeutic targets. Here we analyzed the plasma oxytocin and prolactin levels during an FEP, assessing their correlation with clinical and cognitive features.

Methods: The oxytocin and prolactin in plasma was measured in 120 FEP patients and 106 healthy controls, all of whom were subjected to a clinical and neuropsychological assessment. Most patients were under antipsychotics. Statistical analyses aimed to identify factors associated with the FEP and to search for associations between the variables. This study is preliminary and exploratory because the P-values were not corrected for multiple comparisons.

Results: FEP patients had less oxytocin, more prolactin, and a poor premorbid IQ, and they performed worse in sustained attention. Male patients with higher prolactin levels experienced more severe psychotic symptoms and required higher doses of antipsychotics. Low oxytocin was associated with poor sustained attention in women, whereas low oxytocin and high prolactin in men correlated with better performance in sustained attention.

Conclusion: Low oxytocin, high prolactin, and poor premorbid IQ and sustained attention are factors associated with an FEP, representing potential therapeutic targets in these patients. These biological factors and cognitive domains might play an important role during a FEP, which could help us to develop new strategies that improve the outcomes of this disorder and that should perhaps be gender specific.

Citing Articles

Oxytocin in old age psychiatry: A systematic review of the safety of using intranasal oxytocin in older adults.

Sawares A, Olver J, Morcos M, Norman T Australas Psychiatry. 2024; 33(1):33-44.

PMID: 39474844 PMC: 11804147. DOI: 10.1177/10398562241291335.


Antipsychotic-induced prolactin elevation in premenopausal women with schizophrenia: associations with estrogen, disease severity and cognition.

Brand B, de Boer J, Willemse E, Weickert C, Sommer I, Weickert T Arch Womens Ment Health. 2024; 27(6):931-941.

PMID: 38995314 PMC: 11579114. DOI: 10.1007/s00737-024-01491-9.


GDNF and miRNA-29a as biomarkers in the first episode of psychosis: uncovering associations with psychosocial factors.

Szwajca M, Kazek G, Smierciak N, Mizera J, Pomierny-Chamiolo L, Szwajca K Front Psychiatry. 2024; 15:1320650.

PMID: 38645418 PMC: 11027163. DOI: 10.3389/fpsyt.2024.1320650.


Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up.

Hidalgo-Figueroa M, Salazar A, Romero-Lopez-Alberca C, MacDowell K, Garcia-Bueno B, Bioque M Int J Neuropsychopharmacol. 2023; 26(11):796-807.

PMID: 37603404 PMC: 10674080. DOI: 10.1093/ijnp/pyad051.


Assessment of Tissue Expression of the Oxytocin-Vasopressin Pathway in the Placenta of Women with a First-Episode Psychosis during Pregnancy.

Ortega M, Garcia-Montero C, Fraile-Martinez O, De Leon-Oliva D, Boaru D, Bravo C Int J Mol Sci. 2023; 24(12).

PMID: 37373400 PMC: 10299487. DOI: 10.3390/ijms241210254.


References
1.
Garcia-Bueno B, Bioque M, MacDowell K, Santabarbara J, Martinez-Cengotitabengoa M, Moreno C . Pro-/antiinflammatory dysregulation in early psychosis: results from a 1-year follow-up study. Int J Neuropsychopharmacol. 2015; 18(2). PMC: 4368893. DOI: 10.1093/ijnp/pyu037. View

2.
Labad J . The role of cortisol and prolactin in the pathogenesis and clinical expression of psychotic disorders. Psychoneuroendocrinology. 2018; 102:24-36. DOI: 10.1016/j.psyneuen.2018.11.028. View

3.
Kirsch P . Oxytocin in the socioemotional brain: implications for psychiatric disorders. Dialogues Clin Neurosci. 2016; 17(4):463-76. PMC: 4734884. View

4.
Penades R, Garcia-Rizo C, Bioque M, Gonzalez-Rodriguez A, Cabrera B, Mezquida G . The search for new biomarkers for cognition in schizophrenia. Schizophr Res Cogn. 2017; 2(4):172-178. PMC: 5609637. DOI: 10.1016/j.scog.2015.10.004. View

5.
Gonzalez-Blanco L, Greenhalgh A, Garcia-Rizo C, Fernandez-Egea E, Miller B, Kirkpatrick B . Prolactin concentrations in antipsychotic-naïve patients with schizophrenia and related disorders: A meta-analysis. Schizophr Res. 2016; 174(1-3):156-160. DOI: 10.1016/j.schres.2016.03.018. View